Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort

Genome Biology

Volumn 18, Issue 1, 2017, Pages

  Org, Elin ^a,b   Blum, Yuna ^a   Kasela, Silva ^b   Mehrabian, Margarete ^a   Kuusisto, Johanna ^c,d   Kangas, Antti J ^e   Soininen, Pasi ^c,e   Wang, Zeneng ^f   Ala Korpela, Mika ^c,e,g   Hazen, Stanley L ^f   Laakso, Markku ^c,d   Lusis, Aldons J ^a,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Host microbiota interactions; Metabolic traits; Serum metabolites; TMAO; Type 2 diabetes

Indexed keywords

AMINO ACID; FATTY ACID; GLUCOSE; LIPID; RNA 16S; TRIMETHYLAMINE OXIDE; GLUCOSE BLOOD LEVEL; METHYLAMINE; TRIMETHYLOXAMINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BACTEROIDES; BODY MASS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMMUNITY STRUCTURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FINN (CITIZEN); GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTESTINE FLORA; LACHNOSPIRACEAE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLITE; METHANOBREVIBACTER; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; OBESITY; PHENOTYPE; RUMINOCOCCACEAE; SPECIES RICHNESS; WEIGHTED GENE CO-EXPRESSION NETWORK ANALYSIS; BACTERIUM; BLOOD; CLASSIFICATION; GLUCOSE TOLERANCE TEST; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

AGED; AMINO ACIDS; BACTERIA; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; GASTROINTESTINAL MICROBIOME; GLUCOSE TOLERANCE TEST; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; METHYLAMINES; MICROBIOTA; MIDDLE AGED; PHENOTYPE;

EID: 85018464842     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/s13059-017-1194-2     Document Type: Article

References (72)

1. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99-103. http://www.ncbi.nlm.nih.gov/pubmed/23719380.
2. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55-60. http://www.ncbi.nlm.nih.gov/pubmed/23023125.
3. Parks BW, Nam E, Org E, Kostem E, Norheim F, Hui ST, et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 2013;17:141-52. http://dx.doi.org/10.1016/j.cmet.2012.12.007.
4. Dumas M-E, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A. 2006;103:12511-6. http://www.ncbi.nlm.nih.gov/pubmed/16895997.
5. Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376-81. http://www.ncbi.nlm.nih.gov/pubmed/27409811.
6. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-6. http://www.ncbi.nlm.nih.gov/pubmed/23985870.
7. Ussar S, Griffin NW, Bezy O, Fujisaka S, Vienberg S, Softic S, et al. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab. 2015;22:516-30. http://www.ncbi.nlm.nih.gov/pubmed/26299453.
8. Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165:111-24. http://www.ncbi.nlm.nih.gov/pubmed/26972052.
9. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57-63. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3086762&tool=pmcentrez&rendertype=abstract.
10. Tang WHW, Wang Z, Shrestha K, Borowski AG, Wu Y, Troughton RW, et al. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J Card Fail. 2015;21:91-6. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4312712&tool=pmcentrez&rendertype=abstract.
11. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 2016;7:185. http://www.ncbi.nlm.nih.gov/pubmed/26925050.
12. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576-85. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3650111&tool=pmcentrez&rendertype=abstract.
13. Tang WHW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116:448-55. http://www.ncbi.nlm.nih.gov/pubmed/25599331.
14. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105-8. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368382&tool=pmcentrez&rendertype=abstract.
15. Org E, Parks BW, Joo JWJ, Emert B, Schwartzman W, Kang EY, et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res. 2015;25:1558-69. http://genome.cshlp.org/content/25/10/1558.long.
16. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. Human genetics shape the gut microbiome. Cell. 2014;159:789-99. http://www.ncbi.nlm.nih.gov/pubmed/25417156.
17. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242-9. http://www.ncbi.nlm.nih.gov/pubmed/22972297.
18. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, et al. Population-level analysis of gut microbiome variation. Science. 2016;352:560-4. http://www.ncbi.nlm.nih.gov/pubmed/27126039.
19. Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352:565-9. http://www.ncbi.nlm.nih.gov/pubmed/27126040.
20. Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JAM, et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res. 2015;117:817-24. http://www.ncbi.nlm.nih.gov/pubmed/26358192.
21. Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes. 2009;58:1212-21. http://www.ncbi.nlm.nih.gov/pubmed/19223598.
22. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008;57:1605-15. http://www.ncbi.nlm.nih.gov/pubmed/18941009.
23. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174-80. http://www.ncbi.nlm.nih.gov/pubmed/21508958.
24. Knights D, Ward TL, McKinlay CE, Miller H, Gonzalez A, McDonald D, et al. Rethinking "enterotypes". Cell Host Microbe. 2014;16:433-7. http://www.ncbi.nlm.nih.gov/pubmed/25299329.
25. Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8:192-206. http://www.ncbi.nlm.nih.gov/pubmed/25691689.
26. Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res. 2009;48:44-51. http://www.ncbi.nlm.nih.gov/pubmed/19032965.
27. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol. 2009;9:737-43. http://www.ncbi.nlm.nih.gov/pubmed/19628432.
28. Karlsson F, Tremaroli V, Nielsen J, Bäckhed F. Assessing the human gut microbiota in metabolic diseases. Diabetes. 2013;62:3341-9. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3781439&tool=pmcentrez&rendertype=abstract.
29. de Souza AZZ, Zambom AZ, Abboud KY, Reis SK, Tannihão F, Guadagnini D, et al. Oral supplementation with L-glutamine alters gut microbiota of obese and overweight adults: A pilot study. Nutrition. 2015;31:884-9. http://www.ncbi.nlm.nih.gov/pubmed/25933498.
30. Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125:2222-31. http://www.ncbi.nlm.nih.gov/pubmed/22496159.
31. Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 2014;20:799-812. http://www.cell.com/article/S1550413114004537/fulltext.
32. Gregory JC, Buffa JA, Org E, Wang Z, Levison BS, Zhu W, et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem. 2015;290:5647-60. http://www.ncbi.nlm.nih.gov/pubmed/25550161.
33. Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, et al. Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-ΚB. J Am Heart Assoc. 2016;5. http://www.ncbi.nlm.nih.gov/pubmed/26903003.
34. Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575-84. http://www.nejm.org/doi/abs/10.1056/NEJMoa1109400.
35. Chen M, Yi L, Zhang Y, Zhou X, Ran L, Yang J, et al. Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. MBio. 2016;7:e02210-5. http://www.ncbi.nlm.nih.gov/pubmed/27048804.
36. Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong M-L, et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J. 2013;13:514-22. http://www.nature.com/doifinder/10.1038/tpj.2012.43.
37. Rajilić-Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141:1792-801.
38. Genuth S, Alberti KGMM, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7. http://www.ncbi.nlm.nih.gov/pubmed/14578255.
39. Million M, Angelakis E, Maraninchi M, Henry M, Giorgi R, Valero R, et al. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int J Obes (Lond). 2013;37:1460-6. http://www.ncbi.nlm.nih.gov/pubmed/23459324.
40. Louis P, Scott KP, Duncan SH, Flint HJ. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol. 2007;102:1197-208. http://www.ncbi.nlm.nih.gov/pubmed/17448155.
41. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31. http://dx.doi.org/10.1038/nature05414.
42. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18:190-5. http://www.ncbi.nlm.nih.gov/pubmed/19498350.
43. Everard A, Lazarevic V, Gaïa N, Johansson M, Ståhlman M, Backhed F, et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014;8:2116-30. http://www.nature.com/doifinder/10.1038/ismej.2014.45.
44. Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun. 2014;5:3611. http://www.ncbi.nlm.nih.gov/pubmed/24781306.
45. Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature. 2016;534:213-7. http://www.ncbi.nlm.nih.gov/pubmed/27279214.
46. Hui ST, Parks BW, Org E, Norheim F, Che N, Pan C, et al. The genetic architecture of NAFLD among inbred strains of mice. Elife. 2015;4. http://www.ncbi.nlm.nih.gov/pubmed/26067236.
47. Baylin A, Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol. 2006;17:22-7. http://www.ncbi.nlm.nih.gov/pubmed/16407712.
48. Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G, et al. High-fat diet alters gut microbiota physiology in mice. ISME J. 2014;8:295-308. http://www.nature.com/doifinder/10.1038/ismej.2013.155.
49. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559-63. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3957428&tool=pmcentrez&rendertype=abstract.
50. Alcock J, Lin HC. Fatty acids from diet and microbiota regulate energy metabolism. F1000Research. 2015;4:738. http://www.ncbi.nlm.nih.gov/pubmed/27006755.
51. Mani V, Hollis JH, Gabler NK. 2013. Nutr Metab (Lond). 2013;10:6. http://www.ncbi.nlm.nih.gov/pubmed/23305038.
52. Summers LKM, Fielding BA, Bradshaw HA, Ilic V, Beysen C, Clark ML, et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002;45:369-77. http://www.ncbi.nlm.nih.gov/pubmed/11914742.
53. Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, Inoue H, et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 2015;15:100. http://www.ncbi.nlm.nih.gov/pubmed/26261039.
54. Juste C, Kreil DP, Beauvallet C, Guillot A, Vaca S, Carapito C, et al. Bacterial protein signals are associated with Crohn's disease. Gut. 2014;63:1566-77. http://www.ncbi.nlm.nih.gov/pubmed/24436141.
55. Bonder MJ, Kurilshikov A, Tigchelaar EF, Mujagic Z, Imhann F, Vila AV, et al. The effect of host genetics on the gut microbiome. Nat Genet. 2016. http://www.ncbi.nlm.nih.gov/pubmed/27694959
56. Eren AM, Sogin ML, Morrison HG, Vineis JH, Fisher JC, Newton RJ, et al. A single genus in the gut microbiome reflects host preference and specificity. ISME J. 2015;9:90-100. http://www.ncbi.nlm.nih.gov/pubmed/24936765.
57. McHardy IH, Goudarzi M, Tong M, Ruegger PM, Schwager E, Weger JR, et al. Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome. 2013;1:17. http://www.ncbi.nlm.nih.gov/pubmed/24450808.
58. Poretsky R, Rodriguez-R LM, Luo C, Tsementzi D, Konstantinidis KT, Costello E, et al. Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PLoS One. 2014;9, e93827. http://dx.plos.org/10.1371/journal.pone.0093827.
59. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. Human genetics shape the gut microbiome. Cell. 2014;159:789-99. http://www.sciencedirect.com/science/article/pii/S0092867414012410.
60. Zhou X, Meile L, Kreuzer M, Zeitz JO. The effect of saturated fatty acids on methanogenesis and cell viability of Methanobrevibacter ruminantium. Archaea. 2013;2013:106916. http://www.ncbi.nlm.nih.gov/pubmed/23710130.
61. Bolnick DI, Snowberg LK, Hirsch PE, Lauber CL, Org E, Parks B, et al. Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat Commun. 2014;5:4500. http://www.ncbi.nlm.nih.gov/pubmed/25072318.
62. Org E, Mehrabian M, Parks BW, Shipkova P, Liu X, Drake TA, et al. Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes. 2016;7:313-22. http://www.ncbi.nlm.nih.gov/pubmed/27355107.
63. Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, Delgado-Lista J, et al. Intestinal microbiota is influenced by gender and body mass index. PLoS One. 2016;11, e0154090. http://www.ncbi.nlm.nih.gov/pubmed/27228093.
64. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335-6. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3156573&tool=pmcentrez&rendertype=abstract.
65. Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI, Knight R, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 2013;10:57-9. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3531572&tool=pmcentrez&rendertype=abstract.
66. Edgar RC. Quality measures for protein alignment benchmarks. Nucleic Acids Res. 2010;38:2145-53. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2853116&tool=pmcentrez&rendertype=abstract.
67. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6:610-8. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3280142&tool=pmcentrez&rendertype=abstract.
68. Würtz P, Havulinna AS, Soininen P, Tynkkynen T, Prieto-Merino D, Tillin T, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131:774-85. http://www.ncbi.nlm.nih.gov/pubmed/25573147.
69. Ritchie SC, Würtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, et al. The biomarker GlycA is associated with chronic inflammation and predicts long-term risk of severe infection. Cell Syst. 2015;1:293-301. http://www.ncbi.nlm.nih.gov/pubmed/27136058.
70. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. http://www.ncbi.nlm.nih.gov/pubmed/19114008.
71. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 2008;24:719-20. http://www.ncbi.nlm.nih.gov/pubmed/18024473.
72. Langfelder P, Luo R, Oldham MC, Horvath S. Is my network module preserved and reproducible PLoS Comput Biol. 2011;7, e1001057. http://dx.plos.org/10.1371/journal.pcbi.1001057.